0591-3982

Generic: celecoxib

Labeler: actavis pharma, inc.
NDC Directory DRUG FOR FURTHER PROCESSING DRUG FOR FURTHER PROCESSING Active

Drug Facts

Product Profile

Brand Name
Generic Name celecoxib
Labeler actavis pharma, inc.
Dosage Form CAPSULE
Active Ingredients

celecoxib 50 mg/1

Identifiers & Regulatory

Product NDC 0591-3982
Product ID 0591-3982_909300ab-8281-4b94-90c6-c124316e9faa
Product Type DRUG FOR FURTHER PROCESSING
Marketing Category DRUG FOR FURTHER PROCESSING
Listing Expiration 2026-12-31
Marketing Start 2015-03-12

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05913982
Hyphenated Format 0591-3982

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name celecoxib (source: label)
Generic Name celecoxib (source: ndc)
Application Number ANDA200562 (source: label)
Routes
oral
source: label

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 28735 CAPSULE in 1 CONTAINER (0591-3982-00)
source: ndc

Packages (1)

Ingredients (1)

celecoxib (50 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"spl_id": "909300ab-8281-4b94-90c6-c124316e9faa", "openfda": {}, "finished": false, "packaging": [{"description": "28735 CAPSULE in 1 CONTAINER (0591-3982-00)", "package_ndc": "0591-3982-00", "marketing_start_date": "12-MAR-15"}], "product_id": "0591-3982_909300ab-8281-4b94-90c6-c124316e9faa", "dosage_form": "CAPSULE", "product_ndc": "0591-3982", "generic_name": "Celecoxib", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "CELECOXIB", "strength": "50 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20150312", "listing_expiration_date": "20261231"}